Aisling Capital Management Lp Portfolio Stock Holdings
According to the SEC 13F filed on August 13, 2026, Aisling Capital Management Lp disclosed 13 stock positions valued at approximately $471.62M as of quarter-end June 30, 2026. The largest holdings include BRIDGEBIO PHARMA INC, MONTE ROSA THERAPEUTICS INC, and SYNDAX PHARMACEUTICALS INC.
- Report Period
- June 30, 2026
- No. of Stocks
- 13
- Portfolio Value
- $471.62M
Holdings by Sector
Aisling Capital Management Lp Portfolio Holdings in Q2 2026
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| BRIDGEBIO PHARMA INC | BBIO | Healthcare | 72.48% | 4,589,611 | -500,000 | -9.82% | $341,834,227 |
| MONTE ROSA THERAPEUTICS INC | GLUE | Healthcare | 7.98% | 1,555,664 | - | - | $37,647,069 |
| SYNDAX PHARMACEUTICALS INC | SNDX | Healthcare | 6.10% | 1,316,806 | - | - | $28,785,379 |
| COMPASS PATHWAYS PLC | CMPS | Healthcare | 4.30% | 1,432,336 | - | - | $20,267,554 |
| BICARA THERAPEUTICS INC | BCAX | Other | 3.58% | 568,919 | - | - | $16,891,205 |
| BRIDGEBIO ONCOLOGY THERAPEUT | BBOT | Other | 1.64% | 1,018,018 | - | - | $7,757,297 |
| SCHOLAR ROCK HLDG CORP | SRRK | Healthcare | 0.90% | 77,031 | - | - | $4,236,705 |
| BIOMEA FUSION INC | BMEA | Healthcare | 0.64% | 2,048,757 | - | - | $3,011,673 |
| ACLARIS THERAPEUTICS INC | ACRS | Healthcare | 0.49% | 434,455 | - | - | $2,298,267 |
| EUPRAXIA PHARMACEUTICALS INC | EPRX | Other | 0.46% | 325,000 | - | - | $2,148,250 |
| VTV THERAPEUTICS INC | VTVT | Healthcare | 0.40% | 50,000 | +50,000 | +100.00% | $1,882,500 |
| MARKER THERAPEUTICS INC | MRKR | Healthcare | 0.10% | 325,370 | - | - | $478,293 |
| ONKURE THERAPEUTICS INC | OKUR | Other | 0.09% | 88,607 | - | - | $404,048 |
Showing 13 of 13 holdings in the latest reporting period.